These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 11886464)

  • 41. Various regimens for prophylactic treatment of patients with haemophilia.
    Schwarz R; Ljung R; Tedgård U
    Eur J Haematol; 2015 Feb; 94 Suppl 77():11-6. PubMed ID: 25560789
    [TBL] [Abstract][Full Text] [Related]  

  • 42. FEIBA in treatment of acute bleeding episodes in patients with haemophilia A and factor VIII inhibitors: a retrospective survey in regional haemophilia centre.
    Smejkal P; Brabec P; Matyskova M; Bulikova A; Slechtova M; Kissova J; Chlupova G; Muzik J; Penka M
    Haemophilia; 2009 May; 15(3):743-51. PubMed ID: 19432925
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prophylaxis in adults with haemophilia.
    Hay CR
    Haemophilia; 2007 Sep; 13 Suppl 2():10-5. PubMed ID: 17685918
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modelling lifelong effects of different prophylactic treatment strategies for severe haemophilia A.
    Fischer K; Lewandowski D; Janssen MP
    Haemophilia; 2016 Sep; 22(5):e375-82. PubMed ID: 27353496
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optimizing factor prophylaxis for the haemophilia population: where do we stand?
    Blanchette VS; Manco-Johnson M; Santagostino E; Ljung R
    Haemophilia; 2004 Oct; 10 Suppl 4():97-104. PubMed ID: 15479380
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prophylaxis with anti-inhibitor coagulant complex improves health-related quality of life in haemophilia patients with inhibitors: results from FEIBA NF Prophylaxis Study.
    Stasyshyn O; Antunes S; Mamonov V; Ye X; Epstein J; Xiong Y; Tangada S
    Haemophilia; 2014 Sep; 20(5):644-50. PubMed ID: 24589084
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Haemophilia care in Europe: the ESCHQoL study.
    Schramm W; Gringeri A; Ljung R; Berger K; Crispin A; Bullinger M; Giangrande PL; Von Mackensen S; Mantovani LG; Nemes L; Serban M;
    Haemophilia; 2012 Sep; 18(5):729-37. PubMed ID: 22639833
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The benefits of prophylactic treatment with APCC in patients with haemophilia and high-titre inhibitors: a retrospective case series.
    Valentino LA
    Haemophilia; 2009 May; 15(3):733-42. PubMed ID: 19298380
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The relative burden of haemophilia A and the impact of target joint development on health-related quality of life: results from the ADVATE Post-Authorization Safety Surveillance (PASS) study.
    Klamroth R; Pollmann H; Hermans C; Faradji A; Yarlas AS; Epstein JD; Ewenstein BM
    Haemophilia; 2011 May; 17(3):412-21. PubMed ID: 21332888
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low-dose tertiary prophylactic therapy reduces total number of bleeds and improves the ability to perform activities of daily living in adults with severe haemophilia A: a single-centre experience from Beijing.
    Hua B; Lian X; Li K; Lee A; Poon MC; Zhao Y
    Blood Coagul Fibrinolysis; 2016 Mar; 27(2):136-40. PubMed ID: 26258677
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of secondary prophylaxis started in adolescent and adult haemophiliacs.
    Tagliaferri A; Franchini M; Coppola A; Rivolta GF; Santoro C; Rossetti G; Feola G; Zanon E; Dragani A; Iannaccaro P; Radossi P; Mannucci PM
    Haemophilia; 2008 Sep; 14(5):945-51. PubMed ID: 18540895
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationship between factor VIII replacement therapy and joint damage in severe haemophilia.
    Lowe GD
    Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S3-5. PubMed ID: 9351528
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prophylaxis for severe haemophilia: clinical challenges in the absence as well as in the presence of inhibitors.
    Fischer K; Valentino L; Ljung R; Blanchette V
    Haemophilia; 2008 Jul; 14 Suppl 3():196-201. PubMed ID: 18510542
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preference-based valuation of treatment attributes in haemophilia A using web survey.
    Steen Carlsson K; Andersson E; Berntorp E
    Haemophilia; 2017 Nov; 23(6):894-903. PubMed ID: 28851125
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Consequences of switching from prophylactic treatment to on-demand treatment in late teens and early adults with severe haemophilia A: the TEEN/TWEN study.
    Manco-Johnson MJ; Sanders J; Ewing N; Rodriguez N; Tarantino M; Humphries T;
    Haemophilia; 2013 Sep; 19(5):727-35. PubMed ID: 23750875
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epidemiological survey of the orthopaedic status of severe haemophilia A and B patients in France. The French Study Group. secretariat.haemophiles@cch.ap-hop-paris.fr.
    Molho P; Rolland N; Lebrun T; Dirat G; Courpied JP; Croughs T; Duprat I; Sultan Y
    Haemophilia; 2000 Jan; 6(1):23-32. PubMed ID: 10632738
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Haemophilia utilization group study - Part Va (HUGS Va): design, methods and baseline data.
    Zhou ZY; Wu J; Baker J; Curtis R; Forsberg A; Huszti H; Koerper M; Lou M; Miller R; Parish K; Riske B; Shapiro A; Ullman M; Johnson K
    Haemophilia; 2011 Sep; 17(5):729-36. PubMed ID: 21689212
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety and efficacy of a glycoPEGylated rFVIII (turoctocog alpha pegol, N8-GP) in paediatric patients with severe haemophilia A.
    Meunier S; Alamelu J; Ehrenforth S; Hanabusa H; Abdul Karim F; Kavakli K; Khodaie M; Staber J; Stasyshyn O; Yee DL; Rageliene L
    Thromb Haemost; 2017 Aug; 117(9):1705-1713. PubMed ID: 28692108
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Health-related quality of life and productivity impact in haemophilia patients with inhibitors.
    Brown TM; Lee WC; Joshi AV; Pashos CL
    Haemophilia; 2009 Jul; 15(4):911-7. PubMed ID: 19473410
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hemophilia and prophylaxis.
    Ljung R
    Pediatr Blood Cancer; 2013; 60 Suppl 1():S23-6. PubMed ID: 23109472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.